Immune Design CS
(IMDZ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Sales | 516 | 729 | 5,465 | 2,058 | 8,206 |
| Cost of Goods | 16 | 18 | 37 | 134 | 72 |
| Gross Profit | 500 | 711 | 5,428 | 1,924 | 8,134 |
| Operating Expenses | 14,171 | 14,769 | 18,210 | 16,582 | 20,799 |
| Operating Income | -13,655 | -14,040 | -12,745 | -14,524 | -12,593 |
| Other Income | 239 | 194 | 125 | 78 | 150 |
| Pre-tax Income | -13,416 | -13,846 | -12,620 | -14,446 | -12,443 |
| Net Income Continuous | -13,416 | -13,846 | -12,620 | -14,446 | -12,443 |
| Net Income | $-13,416 | $-13,846 | $-12,620 | $-14,446 | $-12,443 |
| EPS Basic Total Ops | -0.52 | -0.54 | -0.50 | -0.55 | -0.60 |
| EPS Basic Continuous Ops | -0.52 | -0.54 | -0.50 | -0.55 | -0.60 |
| EPS Diluted Total Ops | -0.52 | -0.54 | -0.50 | -0.55 | -0.60 |
| EPS Diluted Continuous Ops | -0.52 | -0.54 | -0.50 | -0.55 | -0.60 |
| EPS Diluted Before Non-Recurring Items | -0.52 | -0.54 | -0.50 | N/A | N/A |
| EBITDA(a) | $-13,579 | $-13,920 | $-12,640 | $-14,292 | $-12,518 |